An atlas of epithelial cell states and plasticity in lung adenocarcinoma.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
28 Feb 2024
Historique:
received: 10 05 2022
accepted: 24 01 2024
pubmed: 29 2 2024
medline: 29 2 2024
entrez: 28 2 2024
Statut: aheadofprint

Résumé

Understanding the cellular processes that underlie early lung adenocarcinoma (LUAD) development is needed to devise intervention strategies

Identifiants

pubmed: 38418883
doi: 10.1038/s41586-024-07113-9
pii: 10.1038/s41586-024-07113-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL130129
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : U2C CA233238
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA205608
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA272863
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL153511
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA264583
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA217789
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2024. The Author(s).

Références

Kadara, H., Scheet, P., Wistuba, I. I. & Spira, A. E. Early events in the molecular pathogenesis of lung cancer. Cancer Prev. Res. 9, 518–527 (2016).
doi: 10.1158/1940-6207.CAPR-15-0400
Cardarella, S. & Johnson, B. E. The impact of genomic changes on treatment of lung cancer. Am. J. Respir. Crit. Care Med. 188, 770–775 (2013).
pubmed: 23841470 pmcid: 3826273 doi: 10.1164/rccm.201305-0843PP
Timar, J. The clinical relevance of KRAS gene mutation in non-small-cell lung cancer. Curr. Opin. Oncol. 26, 138–144 (2014).
pubmed: 24463346 doi: 10.1097/CCO.0000000000000051
Tomasini, P., Walia, P., Labbe, C., Jao, K. & Leighl, N. B. Targeting the KRAS pathway in non-small cell lung cancer. Oncologist 21, 1450–1460 (2016).
pubmed: 27807303 pmcid: 5153335 doi: 10.1634/theoncologist.2015-0084
Kadara, H. et al. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer. J. Natl Cancer Inst. 106, dju004 (2014).
pubmed: 24563515 pmcid: 3982778 doi: 10.1093/jnci/dju004
Belinsky, S. A. et al. Aberrant methylation of p16
pubmed: 9751761 pmcid: 21736 doi: 10.1073/pnas.95.20.11891
Belinsky, S. A. et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 62, 2370–2377 (2002).
pubmed: 11956099
Franklin, W. A. et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J. Clin. Invest. 100, 2133–2137 (1997).
pubmed: 9329980 pmcid: 508406 doi: 10.1172/JCI119748
Spira, A. et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat. Med. 13, 361–366 (2007).
pubmed: 17334370 doi: 10.1038/nm1556
Spira, A., Halmos, B. & Powell, C. A. Update in lung cancer 2014. Am. J. Respir. Crit. Care Med. 192, 283–294 (2015).
pubmed: 26230235 pmcid: 4584253 doi: 10.1164/rccm.201504-0756UP
Steiling, K., Ryan, J., Brody, J. S. & Spira, A. The field of tissue injury in the lung and airway. Cancer Prev. Res. 1, 396–403 (2008).
doi: 10.1158/1940-6207.CAPR-08-0174
Wistuba, I. I. et al. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl Cancer Inst. 89, 1366–1373 (1997).
pubmed: 9308707 doi: 10.1093/jnci/89.18.1366
Lambrechts, D. et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277–1289 (2018).
pubmed: 29988129 doi: 10.1038/s41591-018-0096-5
Maynard, A. et al. Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell 182, 1232–1251.e22 (2020).
pubmed: 32822576 pmcid: 7484178 doi: 10.1016/j.cell.2020.07.017
Sinjab, A. et al. Resolving the spatial and cellular architecture of lung adenocarcinoma by multiregion single-cell sequencing. Cancer Discov. 11, 2506–2523 (2021).
pubmed: 33972311 pmcid: 8487926 doi: 10.1158/2159-8290.CD-20-1285
Tirosh, I. et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539, 309–313 (2016).
pubmed: 27806376 pmcid: 5465819 doi: 10.1038/nature20123
McFadden, D. G. et al. Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma. Proc. Natl Acad. Sci. USA 113, E6409–E6417 (2016).
pubmed: 27702896 pmcid: 5081629 doi: 10.1073/pnas.1613601113
Gulati, G. S. et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367, 405–411 (2020).
pubmed: 31974247 pmcid: 7694873 doi: 10.1126/science.aax0249
Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598–606 (2023).
pubmed: 37258682 doi: 10.1038/s41586-023-06130-4
Treutlein, B. et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature 509, 371–375 (2014).
pubmed: 24739965 pmcid: 4145853 doi: 10.1038/nature13173
Fujimoto, J. et al. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a. Int. J. Cancer 141, 1589–1599 (2017).
pubmed: 28653505 pmcid: 5774849 doi: 10.1002/ijc.30851
Westcott, P. M. et al. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature 517, 489–492 (2015).
pubmed: 25363767 doi: 10.1038/nature13898
Sinjab, A., Han, G., Wang, L. & Kadara, H. Field carcinogenesis in cancer evolution: what the cell is going on? Cancer Res. 80, 4888–4891 (2020).
pubmed: 33023945 pmcid: 7669616 doi: 10.1158/0008-5472.CAN-20-1956
Snyder, E. L. et al. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol. Cell 50, 185–199 (2013).
pubmed: 23523371 pmcid: 3721642 doi: 10.1016/j.molcel.2013.02.018
Strunz, M. et al. Alveolar regeneration through a Krt8
pubmed: 32678092 pmcid: 7366678 doi: 10.1038/s41467-020-17358-3
Choi, J. et al. Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration. Cell Stem Cell 27, 366–382.e7 (2020).
pubmed: 32750316 pmcid: 7487779 doi: 10.1016/j.stem.2020.06.020
Fujimoto, J. et al. Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice. PLoS ONE 5, e11847 (2010).
pubmed: 20686609 pmcid: 2912294 doi: 10.1371/journal.pone.0011847
Marjanovic, N. D. et al. Emergence of a high-plasticity cell state during lung cancer evolution. Cancer Cell 38, 229–246.e13 (2020).
pubmed: 32707077 pmcid: 7745838 doi: 10.1016/j.ccell.2020.06.012
Dost, A. F. M. et al. Organoids model transcriptional hallmarks of oncogenic KRAS activation in lung epithelial progenitor cells. Cell Stem Cell 27, 663–678.e8 (2020).
pubmed: 32891189 pmcid: 7541765 doi: 10.1016/j.stem.2020.07.022
Hallin, J. et al. Anti-tumor efficacy of a potent and selective non-covalent KRAS
pubmed: 36216931 doi: 10.1038/s41591-022-02007-7
Wislez, M. et al. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res. 65, 3226–3235 (2005).
pubmed: 15833854 doi: 10.1158/0008-5472.CAN-04-4420
Hill, W. et al. Lung adenocarcinoma promotion by air pollutants. Nature 616, 159–167 (2023).
pubmed: 37020004 pmcid: 7614604 doi: 10.1038/s41586-023-05874-3
Kadara, H. et al. Driver mutations in normal airway epithelium elucidate spatiotemporal resolution of lung cancer. Am. J. Respir. Crit. Care Med. 200, 742–750 (2019).
Salgia, R., Pharaon, R., Mambetsariev, I., Nam, A. & Sattler, M. The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC). Cell Rep. Med. 2, 100186 (2021).
pubmed: 33521700 pmcid: 7817862 doi: 10.1016/j.xcrm.2020.100186
Lin, C. et al. Alveolar type II cells possess the capability of initiating lung tumor development. PLoS ONE 7, e53817 (2012).
pubmed: 23285300 pmcid: 3527621 doi: 10.1371/journal.pone.0053817
Liu, B. et al. An entropy-based metric for assessing the purity of single cell populations. Nat. Commun. 11, 3155 (2020).
pubmed: 32572028 pmcid: 7308400 doi: 10.1038/s41467-020-16904-3
Xu, X. et al. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc. Natl Acad. Sci. USA 109, 4910–4915 (2012).
pubmed: 22411819 pmcid: 3323959 doi: 10.1073/pnas.1112499109
Kobayashi, Y. et al. Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis. Nat. Cell Biol. 22, 934–946 (2020).
pubmed: 32661339 pmcid: 7461628 doi: 10.1038/s41556-020-0542-8
Kaiser, A. M. et al. p53 governs an AT1 differentiation programme in lung cancer suppression. Nature 619, 851–859 (2023).
pubmed: 37468633 doi: 10.1038/s41586-023-06253-8
Slyper, M. et al. A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors. Nat. Med. 26, 792–802 (2020).
pubmed: 32405060 pmcid: 7220853 doi: 10.1038/s41591-020-0844-1
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096
Wang, R. et al. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat. Med. 27, 141–151 (2021).
pubmed: 33398161 pmcid: 8074162 doi: 10.1038/s41591-020-1125-8
McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329–337.e4 (2019).
pubmed: 30954475 pmcid: 6853612 doi: 10.1016/j.cels.2019.03.003
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693 doi: 10.1038/s41592-019-0619-0
McInnes, L., Healy, J. & Melville, J. UMAP: uniform manifold approximation and projection for dimension reduction. Preprint at https://arxiv.org/abs/1802.03426 (2018).
Robinson, J. T., Thorvaldsdottir, H., Wenger, A. M., Zehir, A. & Mesirov, J. P. Variant review with the Integrative Genomics Viewer. Cancer Res. 77, e31–e34 (2017).
pubmed: 29092934 pmcid: 5678989 doi: 10.1158/0008-5472.CAN-17-0337
Sjostedt, E. et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367, eaay5947 (2020).
pubmed: 32139519 doi: 10.1126/science.aay5947
Travaglini, K. J. et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature 587, 619–625 (2020).
pubmed: 33208946 pmcid: 7704697 doi: 10.1038/s41586-020-2922-4
Maroni, G. et al. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer. Commun. Biol. 4, 370 (2021).
pubmed: 33854168 pmcid: 8046784 doi: 10.1038/s42003-021-01897-6
Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496–502 (2019).
pubmed: 30787437 pmcid: 6434952 doi: 10.1038/s41586-019-0969-x
Setty, M. et al. Characterization of cell fate probabilities in single-cell data with Palantir. Nat. Biotechnol. 37, 451–460 (2019).
pubmed: 30899105 pmcid: 7549125 doi: 10.1038/s41587-019-0068-4
Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).
pubmed: 29914354 pmcid: 6007078 doi: 10.1186/s12864-018-4772-0
Lange, M. et al. CellRank for directed single-cell fate mapping. Nat. Methods 19, 159–170 (2022).
pubmed: 35027767 pmcid: 8828480 doi: 10.1038/s41592-021-01346-6
Hao, D. et al. The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma. Cancer Discov. 12, 2626–2645 (2022).
pubmed: 36098652 pmcid: 9633381 doi: 10.1158/2159-8290.CD-21-1658
Hu, J. et al. Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA. Cell Syst. 14, 404–417.e4 (2023).
pubmed: 37164011 pmcid: 10246692 doi: 10.1016/j.cels.2023.03.008
Vahid, M. R. et al. High-resolution alignment of single-cell and spatial transcriptomes with CytoSPACE. Nat. Biotechnol. 41, 1543–1548 (2023).
pubmed: 36879008 pmcid: 10635828 doi: 10.1038/s41587-023-01697-9
Wang, R. et al. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 69, 18–31 (2020).
pubmed: 31171626 doi: 10.1136/gutjnl-2018-318070
Hao, D. et al. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 70, 2055–2065 (2021).
pubmed: 33334899 doi: 10.1136/gutjnl-2020-322707
Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213–219 (2013).
pubmed: 23396013 pmcid: 3833702 doi: 10.1038/nbt.2514
Skoulidis, F. et al. Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discov. 5, 860–877 (2015).
pubmed: 26069186 pmcid: 4527963 doi: 10.1158/2159-8290.CD-14-1236
Sivakumar, S. et al. Genomic landscape of atypical adenomatous hyperplasia reveals divergent modes to lung adenocarcinoma. Cancer Res. 77, 6119–6130 (2017).
pubmed: 28951454 pmcid: 5774855 doi: 10.1158/0008-5472.CAN-17-1605
Daouk, R. et al. Genome-wide and phenotypic evaluation of stem cell progenitors derived from Gprc5a-deficient murine lung adenocarcinoma with somatic Kras mutations. Front. Oncol. 9, 207 (2019).
pubmed: 31001473 pmcid: 6454871 doi: 10.3389/fonc.2019.00207
The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543–550 (2014).
pmcid: 4231481 doi: 10.1038/nature13385
Kantrowitz, J. et al. Genome-wide gene expression changes in the normal-appearing airway during the evolution of smoking-associated lung adenocarcinoma. Cancer Prev. Res. 11, 237–248 (2018).
doi: 10.1158/1940-6207.CAPR-17-0295
Tao, Q. et al. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. J. Natl Cancer Inst. 99, 1668–1682 (2007).
pubmed: 18000218 doi: 10.1093/jnci/djm208
Barkauskas, C. E. et al. Type 2 alveolar cells are stem cells in adult lung. J. Clin. Invest. 123, 3025–3036 (2013).
pubmed: 23921127 pmcid: 3696553 doi: 10.1172/JCI68782
Lee, J. H. et al. Lung stem cell differentiation in mice directed by endothelial cells via a BMP4–NFATc1–thrombospondin-1 axis. Cell 156, 440–455 (2014).
pubmed: 24485453 pmcid: 3951122 doi: 10.1016/j.cell.2013.12.039

Auteurs

Guangchun Han (G)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ansam Sinjab (A)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Zahraa Rahal (Z)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Anne M Lynch (AM)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Graduate Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA.

Warapen Treekitkarnmongkol (W)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Yuejiang Liu (Y)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas Health Houston Graduate School of Biomedical Sciences, Houston, TX, USA.

Alejandra G Serrano (AG)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jiping Feng (J)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ke Liang (K)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Khaja Khan (K)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Wei Lu (W)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Sharia D Hernandez (SD)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Yunhe Liu (Y)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Xuanye Cao (X)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Enyu Dai (E)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Guangsheng Pei (G)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jian Hu (J)

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Camille Abaya (C)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Lorena I Gomez-Bolanos (LI)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Fuduan Peng (F)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Minyue Chen (M)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas Health Houston Graduate School of Biomedical Sciences, Houston, TX, USA.

Edwin R Parra (ER)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Tina Cascone (T)

Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Boris Sepesi (B)

Department of Cardiovascular and Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Seyed Javad Moghaddam (SJ)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Paul Scheet (P)

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Marcelo V Negrao (MV)

Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

John V Heymach (JV)

Department of Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mingyao Li (M)

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Steven M Dubinett (SM)

Department of Medicine, The University of California Los Angeles, Los Angeles, CA, USA.

Christopher S Stevenson (CS)

Lung Cancer Initiative at Johnson & Johnson, Boston, MA, USA.

Avrum E Spira (AE)

Lung Cancer Initiative at Johnson & Johnson, Boston, MA, USA.
Section of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA.

Junya Fujimoto (J)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Luisa M Solis (LM)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ignacio I Wistuba (II)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jichao Chen (J)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. JChen16@mdanderson.org.
The University of Texas Health Houston Graduate School of Biomedical Sciences, Houston, TX, USA. JChen16@mdanderson.org.

Linghua Wang (L)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.
The University of Texas Health Houston Graduate School of Biomedical Sciences, Houston, TX, USA. lwang22@mdanderson.org.

Humam Kadara (H)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hkadara@mdanderson.org.
The University of Texas Health Houston Graduate School of Biomedical Sciences, Houston, TX, USA. hkadara@mdanderson.org.

Classifications MeSH